I think the odds are good and that it is important that the N-Assay message gets out. One problem with scientific journals is that you don't get to do multiple submissions but need to do one at a time. This drags out the process and is very frustrating. But the capabilities of the N-Assay and the Faros reputation are things that we should hope leads to an acceptance in a journal that the company can use to trumpet its products to a considerably wider range of investors and consumers. With the other strengths that we have heard that are building sales volumes and attention to the products I assume that the company is waiting out the potential N-Assay publication matter before issuing a press release that I would expect to be a dramatic uptick.